JPS6228157B2 - - Google Patents
Info
- Publication number
- JPS6228157B2 JPS6228157B2 JP53117377A JP11737778A JPS6228157B2 JP S6228157 B2 JPS6228157 B2 JP S6228157B2 JP 53117377 A JP53117377 A JP 53117377A JP 11737778 A JP11737778 A JP 11737778A JP S6228157 B2 JPS6228157 B2 JP S6228157B2
- Authority
- JP
- Japan
- Prior art keywords
- ethyl
- dione
- acid
- pregnene
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 17
- 125000002252 acyl group Chemical group 0.000 claims description 8
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 7
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 7
- 229910052794 bromium Inorganic materials 0.000 claims description 7
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- 229910052740 iodine Inorganic materials 0.000 claims description 6
- 239000011630 iodine Substances 0.000 claims description 6
- 229910052731 fluorine Inorganic materials 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- -1 heterocyclic tertiary amine Chemical class 0.000 claims description 3
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 27
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 24
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 19
- 239000000243 solution Substances 0.000 description 16
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- 239000000284 extract Substances 0.000 description 8
- 239000011541 reaction mixture Substances 0.000 description 8
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 6
- 238000002844 melting Methods 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 5
- 239000005457 ice water Substances 0.000 description 5
- 230000029849 luteinization Effects 0.000 description 5
- 239000012299 nitrogen atmosphere Substances 0.000 description 5
- 150000003431 steroids Chemical class 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000016087 ovulation Effects 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 150000001735 carboxylic acids Chemical class 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 230000000938 luteal effect Effects 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000011152 sodium sulphate Nutrition 0.000 description 3
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 2
- BWZVCCNYKMEVEX-UHFFFAOYSA-N 2,4,6-Trimethylpyridine Chemical compound CC1=CC(C)=NC(C)=C1 BWZVCCNYKMEVEX-UHFFFAOYSA-N 0.000 description 2
- JYYNAJVZFGKDEQ-UHFFFAOYSA-N 2,4-Dimethylpyridine Chemical compound CC1=CC=NC(C)=C1 JYYNAJVZFGKDEQ-UHFFFAOYSA-N 0.000 description 2
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 2
- NURQLCJSMXZBPC-UHFFFAOYSA-N 3,4-dimethylpyridine Chemical compound CC1=CC=NC=C1C NURQLCJSMXZBPC-UHFFFAOYSA-N 0.000 description 2
- JDQNYWYMNFRKNQ-UHFFFAOYSA-N 3-ethyl-4-methylpyridine Chemical compound CCC1=CN=CC=C1C JDQNYWYMNFRKNQ-UHFFFAOYSA-N 0.000 description 2
- FKNQCJSGGFJEIZ-UHFFFAOYSA-N 4-methylpyridine Chemical compound CC1=CC=NC=C1 FKNQCJSGGFJEIZ-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- LQZMLBORDGWNPD-UHFFFAOYSA-N N-iodosuccinimide Chemical compound IN1C(=O)CCC1=O LQZMLBORDGWNPD-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- LJOODBDWMQKMFB-UHFFFAOYSA-N cyclohexylacetic acid Chemical compound OC(=O)CC1CCCCC1 LJOODBDWMQKMFB-UHFFFAOYSA-N 0.000 description 2
- JBDSSBMEKXHSJF-UHFFFAOYSA-N cyclopentanecarboxylic acid Chemical compound OC(=O)C1CCCC1 JBDSSBMEKXHSJF-UHFFFAOYSA-N 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 229960005309 estradiol Drugs 0.000 description 2
- 229930182833 estradiol Natural products 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- LCPDWSOZIOUXRV-UHFFFAOYSA-N phenoxyacetic acid Chemical compound OC(=O)COC1=CC=CC=C1 LCPDWSOZIOUXRV-UHFFFAOYSA-N 0.000 description 2
- 150000003126 pregnane derivatives Chemical class 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- REYHXKZHIMGNSE-UHFFFAOYSA-M silver monofluoride Chemical compound [F-].[Ag+] REYHXKZHIMGNSE-UHFFFAOYSA-M 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- ALSXNTIVNJBNQE-ZWONNITHSA-N (8r,9r,10s,13r,14s,17s)-17-ethyl-13-methyl-1,2,3,4,5,6,7,8,9,10,11,12,14,15,16,17-hexadecahydrocyclopenta[a]phenanthrene Chemical compound C1CC2CCCC[C@@H]2[C@@H]2[C@@H]1[C@@H]1CC[C@H](CC)[C@@]1(C)CC2 ALSXNTIVNJBNQE-ZWONNITHSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- SFVSLWJGURQFMC-UHFFFAOYSA-N 2-cyclooctylacetic acid Chemical compound OC(=O)CC1CCCCCCC1 SFVSLWJGURQFMC-UHFFFAOYSA-N 0.000 description 1
- XWKFPIODWVPXLX-UHFFFAOYSA-N 2-methyl-5-methylpyridine Natural products CC1=CC=C(C)N=C1 XWKFPIODWVPXLX-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- ITQTTZVARXURQS-UHFFFAOYSA-N 3-methylpyridine Chemical compound CC1=CC=CN=C1 ITQTTZVARXURQS-UHFFFAOYSA-N 0.000 description 1
- KNCHDRLWPAKSII-UHFFFAOYSA-N 4-ethyl-2-methylpyridine Chemical compound CCC1=CC=NC(C)=C1 KNCHDRLWPAKSII-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- VPGRYOFKCNULNK-ACXQXYJUSA-N Deoxycorticosterone acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)COC(=O)C)[C@@]1(C)CC2 VPGRYOFKCNULNK-ACXQXYJUSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- JIMXXGFJRDUSRO-UHFFFAOYSA-N adamantane-1-carboxylic acid Chemical compound C1C(C2)CC3CC2CC1(C(=O)O)C3 JIMXXGFJRDUSRO-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001844 chromium Chemical class 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- NQGIJDNPUZEBRU-UHFFFAOYSA-N dodecanoyl chloride Chemical compound CCCCCCCCCCCC(Cl)=O NQGIJDNPUZEBRU-UHFFFAOYSA-N 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- UULXSTDDDXOTIY-UHFFFAOYSA-N n-iodoacetamide Chemical compound CC(=O)NI UULXSTDDDXOTIY-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 150000003128 pregnanes Chemical class 0.000 description 1
- 230000001072 progestational effect Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229940096017 silver fluoride Drugs 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- WRTMQOHKMFDUKX-UHFFFAOYSA-N triiodide Chemical compound I[I-]I WRTMQOHKMFDUKX-UHFFFAOYSA-N 0.000 description 1
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 1
- 238000003828 vacuum filtration Methods 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
- C07J5/0023—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16
- C07J5/003—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes
- C07J5/0038—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes by an alkyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/0025—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16
- C07J7/003—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
- C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
ãçºæã®è©³çŽ°ãªèª¬æã
æ¬çºæã¯ãé»äœæåããã³ïŒåã¯æåµæå¶æŽ»æ§
ãæãããã¬ã°ãã³èªå°äœã®åéã«é¢ãããã®ã§
ããããŸããæ²»çäžã®æäžã«é©ãã圢æ ã®è©²èªå°
äœâå«æçµæç©ã«é¢ããã
ãæãããã¬ã°ãã³èªå°äœã®åéã«é¢ãããã®ã§
ããããŸããæ²»çäžã®æäžã«é©ãã圢æ ã®è©²èªå°
äœâå«æçµæç©ã«é¢ããã
æ¬çºæã®ååç©ã¯ããžãŒã¬ã³æ°ãã®ç±³åœç¹èš±ç¬¬
3631077å·ã«é瀺ããã19âãã«âãã¬ã°ãã³ã«
é¢ä¿ããããã®ã§ãã€ãŠããŸããé»äœæåæåµæ
å¶æŽ»æ§ãæããã
3631077å·ã«é瀺ããã19âãã«âãã¬ã°ãã³ã«
é¢ä¿ããããã®ã§ãã€ãŠããŸããé»äœæåæåµæ
å¶æŽ»æ§ãæããã
ããã«é瀺ãããã¬ã°ãã³ã·ãªã€ãŒãºïŒâ³4,9
âãã¬ã°ãã³ïŒã®æ°èŠã§æçšãªã¹ããã€ãã¯ãäž
èšåŒãæããïŒ ãªããäžèšåŒäžãR1ã¯ïŒšïŒïŒŠïŒOHããã³OR2
ããæã矀ããéžæããããã®ã§ãã€ãŠãR2ã¯
ïŒä¹è³18åã®ççŽ ååãæããã¢ã·ã«ã§ãããã
ã®ã¹ããã€ãã¯ãé¡èã§æå¹ãªé»äœæååã³ïŒå
ã¯æåµæå¶æŽ»æ§ãç¹ã«çµå£çé»äœæå掻æã瀺
ããR1ãã§ãªãããšã奜ãŸãããæ¬çºæã¯ã
ãŸããäžèšåŒã«ããæ°èŠãªã¹ããã€ãã®ïŒçš®ãã
ãã¯ãã以äžãåäœé圢æ ã®æ²»çäžã®æäžã«é©ã
ã圢æ ã§æäŸããé»äœæåããã³ïŒåã¯æåµæå¶
掻æ§ãæããè¬èª¿ååã®è£œé æ³ã«é¢ãããã®ã§ã
ãããŸãããã®æ¹æ³ã«ãã€ãŠåŸãããæ圢ç®çç©
ã«é¢ãããäžèšåŒïŒïŒã®ååç©ãå«æããè¬å€
çµæç©ãåäœé圢æ ïŒè©²ååç©ãïŒæ¥åœãçŽ0.05
ä¹è³2.5mgã奜ãŸããã¯ã0.1ä¹è³ïŒmgïŒã§è¬åŠç
ã«æå¹ãªæ äœã«ãã€ãŠçµå£çã«æäžããããšãã
æããããã®åŠåš ãé²æ¢ããæ¹æ³ãããã«é瀺ã
ããŠãããæ¬çºæã¯ããŸããäžèšåŒïŒïŒã®åå
ç©ã®21âãšã¹ãã«ãïŒâ50mgã®éã§å«æãããé
çµå£æäžã®ããã®é·æäœçšåŠåš 調ç¯å€èª¿ååã«é¢
ããã
âãã¬ã°ãã³ïŒã®æ°èŠã§æçšãªã¹ããã€ãã¯ãäž
èšåŒãæããïŒ ãªããäžèšåŒäžãR1ã¯ïŒšïŒïŒŠïŒOHããã³OR2
ããæã矀ããéžæããããã®ã§ãã€ãŠãR2ã¯
ïŒä¹è³18åã®ççŽ ååãæããã¢ã·ã«ã§ãããã
ã®ã¹ããã€ãã¯ãé¡èã§æå¹ãªé»äœæååã³ïŒå
ã¯æåµæå¶æŽ»æ§ãç¹ã«çµå£çé»äœæå掻æã瀺
ããR1ãã§ãªãããšã奜ãŸãããæ¬çºæã¯ã
ãŸããäžèšåŒã«ããæ°èŠãªã¹ããã€ãã®ïŒçš®ãã
ãã¯ãã以äžãåäœé圢æ ã®æ²»çäžã®æäžã«é©ã
ã圢æ ã§æäŸããé»äœæåããã³ïŒåã¯æåµæå¶
掻æ§ãæããè¬èª¿ååã®è£œé æ³ã«é¢ãããã®ã§ã
ãããŸãããã®æ¹æ³ã«ãã€ãŠåŸãããæ圢ç®çç©
ã«é¢ãããäžèšåŒïŒïŒã®ååç©ãå«æããè¬å€
çµæç©ãåäœé圢æ ïŒè©²ååç©ãïŒæ¥åœãçŽ0.05
ä¹è³2.5mgã奜ãŸããã¯ã0.1ä¹è³ïŒmgïŒã§è¬åŠç
ã«æå¹ãªæ äœã«ãã€ãŠçµå£çã«æäžããããšãã
æããããã®åŠåš ãé²æ¢ããæ¹æ³ãããã«é瀺ã
ããŠãããæ¬çºæã¯ããŸããäžèšåŒïŒïŒã®åå
ç©ã®21âãšã¹ãã«ãïŒâ50mgã®éã§å«æãããé
çµå£æäžã®ããã®é·æäœçšåŠåš 調ç¯å€èª¿ååã«é¢
ããã
ãã®æ°èŠãªååç©ã¯ãåœæ¥è
ã«ãšã€ãŠå
¬ç¥ã®æ¹
æ³ã§èª¿è£œããã°ããã
æ³ã§èª¿è£œããã°ããã
äŸãã°ãçžåœãã10âã«ã«ããã·ââ³ïŒâïŒâ
ã±ãã³ïŒïŒããåºçºããŠããããåœæ¥è ã«å ¬ç¥
ã®è³éŠæ§ãæããé©åœãªè€çŽ ç°åŒç¬¬ïŒçŽã¢ãã³ã®
ååšäžã«æ²çŽ ãããã¯èçŽ ã奜ãŸããã¯æ²çŽ ãšå
å¿ãããããšã«ãã€ãŠåŒïŒïŒã®ååç©ã調補ã
ãããšãã§ããããã®åå¿ã¯ã10âã«ã«ããã·ã«
åºãé€å»ãããŠäºéçµåãïŒ(10)äœã«åæã«çæã
ãããã«ãé«æž©ïŒçŽ35âãšçŽ180âã®éïŒã§äžè¬
ã«è¡ãªãããã
ã±ãã³ïŒïŒããåºçºããŠããããåœæ¥è ã«å ¬ç¥
ã®è³éŠæ§ãæããé©åœãªè€çŽ ç°åŒç¬¬ïŒçŽã¢ãã³ã®
ååšäžã«æ²çŽ ãããã¯èçŽ ã奜ãŸããã¯æ²çŽ ãšå
å¿ãããããšã«ãã€ãŠåŒïŒïŒã®ååç©ã調補ã
ãããšãã§ããããã®åå¿ã¯ã10âã«ã«ããã·ã«
åºãé€å»ãããŠäºéçµåãïŒ(10)äœã«åæã«çæã
ãããã«ãé«æž©ïŒçŽ35âãšçŽ180âã®éïŒã§äžè¬
ã«è¡ãªãããã
è³éŠæ§ãæããé©åœãªè€çŽ ç°åŒç¬¬ïŒçŽã¢ãã³
ã¯ãäŸãã°ãããªãžã³ãαâã³ãªãžã³ãβâã³ãª
ãžã³ãγâã³ãªãžã³ãïŒïŒïŒâã«ããžã³ãïŒïŒïŒ
âã«ããžã³ãïŒïŒïŒâã«ããžã³ããããªã³ãã€ãœ
ãããªã³ãαâãã³ãªã³ãβâãã³ãªã³ãγâã
ã³ãªã³ã§ãããããªãžã³ã®äœ¿çšãæã奜ãŸããã
ã¯ãäŸãã°ãããªãžã³ãαâã³ãªãžã³ãβâã³ãª
ãžã³ãγâã³ãªãžã³ãïŒïŒïŒâã«ããžã³ãïŒïŒïŒ
âã«ããžã³ãïŒïŒïŒâã«ããžã³ããããªã³ãã€ãœ
ãããªã³ãαâãã³ãªã³ãβâãã³ãªã³ãγâã
ã³ãªã³ã§ãããããªãžã³ã®äœ¿çšãæã奜ãŸããã
åºçºç©è³ªãšããŠçšããã¹ããã€ããå®å
šã«æº¶è§£
ããããã«ã第ïŒçŽã¢ãã³ã®éã¯ååïŒããªã
ã¡ãå¹æçïŒã§ãªããã°ãªããªãããã®éã¯ã10
âã«ã«ããã·ââ³ïŒâïŒâã±ãã³ãšéžæãã第ïŒ
çŽã¢ãã³ãšã«äŸåãããåœæ¥è ã«ãã決å®ã®ç¯å²
å ã«ããã
ããããã«ã第ïŒçŽã¢ãã³ã®éã¯ååïŒããªã
ã¡ãå¹æçïŒã§ãªããã°ãªããªãããã®éã¯ã10
âã«ã«ããã·ââ³ïŒâïŒâã±ãã³ãšéžæãã第ïŒ
çŽã¢ãã³ãšã«äŸåãããåœæ¥è ã«ãã決å®ã®ç¯å²
å ã«ããã
ææã®å Žåã«ã¯ããã³ãŒã³ããã«ãšã³ããã·ã¬
ã³ãäºå¡©åã¡ãã¬ã³ãåå¡©åççŽ ãã¯ãããã³ãŒ
ã³ãªã©ã®ä»ã®äžæŽ»æ§ææ©åžéå€åã¯æº¶å€ãååšã
ããŠãããã
ã³ãäºå¡©åã¡ãã¬ã³ãåå¡©åççŽ ãã¯ãããã³ãŒ
ã³ãªã©ã®ä»ã®äžæŽ»æ§ææ©åžéå€åã¯æº¶å€ãååšã
ããŠãããã
䜿çšãã¹ãæ²çŽ ãããã¯èçŽ ã®éã¯ã¹ããã€ã
ïŒïŒã®ã¢ã«åœéåœãçŽïŒã¢ã«åœéã§ããããã®
ããã«ãæ¡çšãããéã¯ãäžè¬ã«ãã¹ããã€ã
ïŒïŒã®ã¢ã«åœéåœã1.0ä¹è³1.1ã¢ã«åœéã§ã
ããæ²çŽ ååãããã¯èçŽ ååã®ä»£ãã«ããŸã
âãšãŒãâã¢ã»ãã¢ãããâãšãŒããŒã¹ã¯ã·ã
ãããããªã¡ãã«ã¢ã³ã¢ããŠã âã¢ã€ãªãã€ãâ
ããŒã¢ã€ãªãã€ããããªãžã³âãâã¢ã€ãªãã€ã
âãã€ããâã¢ã€ãªãã€ããåã¯çžåœããããã¢
ååç©ã®ãããªæ²çŽ âãããã¯èçŽ âæŸåºå€
ïŒreleasing agentïŒãçšããŠãããã
ïŒïŒã®ã¢ã«åœéåœãçŽïŒã¢ã«åœéã§ããããã®
ããã«ãæ¡çšãããéã¯ãäžè¬ã«ãã¹ããã€ã
ïŒïŒã®ã¢ã«åœéåœã1.0ä¹è³1.1ã¢ã«åœéã§ã
ããæ²çŽ ååãããã¯èçŽ ååã®ä»£ãã«ããŸã
âãšãŒãâã¢ã»ãã¢ãããâãšãŒããŒã¹ã¯ã·ã
ãããããªã¡ãã«ã¢ã³ã¢ããŠã âã¢ã€ãªãã€ãâ
ããŒã¢ã€ãªãã€ããããªãžã³âãâã¢ã€ãªãã€ã
âãã€ããâã¢ã€ãªãã€ããåã¯çžåœããããã¢
ååç©ã®ãããªæ²çŽ âãããã¯èçŽ âæŸåºå€
ïŒreleasing agentïŒãçšããŠãããã
é©åœãªåºçºç©è³ªïŒïŒã¯ãäŸãã°ã10βâã«ã«
ããã·â16αâãšãã«ââ³ïŒâãã¬ã°ãã³âïŒïŒ
20âãžãªã³ïŒ10βâã«ã«ããã·â16αâãšãã«â
21âããããã·ââ³ïŒâãã¬ã°ãã³âïŒïŒ20âãž
ãªã³ïŒ10βâã«ã«ããã·â16αâãšãã«â21âã¢
ã·ããã·ââ³ïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³ïŒ
10βâã«ã«ããã·â16αâãšãã«â21âãã«ãªã
ââ³ïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³ã§ããã
ããã·â16αâãšãã«ââ³ïŒâãã¬ã°ãã³âïŒïŒ
20âãžãªã³ïŒ10βâã«ã«ããã·â16αâãšãã«â
21âããããã·ââ³ïŒâãã¬ã°ãã³âïŒïŒ20âãž
ãªã³ïŒ10βâã«ã«ããã·â16αâãšãã«â21âã¢
ã·ããã·ââ³ïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³ïŒ
10βâã«ã«ããã·â16αâãšãã«â21âãã«ãªã
ââ³ïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³ã§ããã
ãã®åºçºç©è³ªïŒïŒã¯ãäŸãã°ãããã«åèãš
ããŠãããç±³åœç¹èš±ç¬¬3631077å·æ现æžã®å®æœäŸ
ã«ç€ºãããããã«ããã¬ã°ãã³ååç©ãã19â
ãã«âãã¬ã°ãã³ååç©ã補é ããããã®å ¬ç¥ã®
æ¹æ³ã§äžéäœãšããŠåœ¢æãããçžåœïŒÎ²âããã
ãã·âïŒÎ±âããã¢âïŒÎ²ïŒ19âãšããã·ååç©
ïŒïŒããã®è£œåã§ãã€ãŠãããããã®ãããªïŒ
βâããããã·âïŒÎ±âããã¢âïŒÎ²ïŒ19âãšã
ãã·âãã¬ã°ãã³èªå°äœã¯ãäŸãã°ãã¯ãã é žã§
æåã«é žåããŠçžåœããïŒâãªããœââ³ïŒâïŒ
βïŒ19âãšããã·ããšãããã€ãã§ãäŸãã°ãã€
ãœãããããŒã«äžã§äºéïŒé ¢é žã§åŠçããã®ã¡ã«
åžç¡«é žã§åŠçããããšã«ãã€ãŠããã®ãšããã·ã
ç°ãéå éç°ãããŠïŒâãªããœââ³ïŒâ19âãã
ããã·âãã¬ã°ãã³èªå°äœãåŸãã
ããŠãããç±³åœç¹èš±ç¬¬3631077å·æ现æžã®å®æœäŸ
ã«ç€ºãããããã«ããã¬ã°ãã³ååç©ãã19â
ãã«âãã¬ã°ãã³ååç©ã補é ããããã®å ¬ç¥ã®
æ¹æ³ã§äžéäœãšããŠåœ¢æãããçžåœïŒÎ²âããã
ãã·âïŒÎ±âããã¢âïŒÎ²ïŒ19âãšããã·ååç©
ïŒïŒããã®è£œåã§ãã€ãŠãããããã®ãããªïŒ
βâããããã·âïŒÎ±âããã¢âïŒÎ²ïŒ19âãšã
ãã·âãã¬ã°ãã³èªå°äœã¯ãäŸãã°ãã¯ãã é žã§
æåã«é žåããŠçžåœããïŒâãªããœââ³ïŒâïŒ
βïŒ19âãšããã·ããšãããã€ãã§ãäŸãã°ãã€
ãœãããããŒã«äžã§äºéïŒé ¢é žã§åŠçããã®ã¡ã«
åžç¡«é žã§åŠçããããšã«ãã€ãŠããã®ãšããã·ã
ç°ãéå éç°ãããŠïŒâãªããœââ³ïŒâ19âãã
ããã·âãã¬ã°ãã³èªå°äœãåŸãã
ãããåŸè
ã®ååç©ããäŸãã°ãã¢ã»ãã³äžã§
ã¯ãã é žã§æçµçã«é žåããŠææã®ïŒâãªããœâ
â³ïŒâ10βâã«ã«ããã·ååç©ã«ããã
ã¯ãã é žã§æçµçã«é žåããŠææã®ïŒâãªããœâ
â³ïŒâ10βâã«ã«ããã·ååç©ã«ããã
10βâã«ã«ããã·ã¹ããã€ããšæ²çŽ ãèçŽ åã¯
æ²çŽ âãããã¯èçŽ âæŸåºå€ïŒreleasing
agentïŒãšã®åå¿åŸã«ãæ¬çºæã«ãã€ãŠãã®ãã
ã«ããŠåŸãããâ³4,9âãã¬ã°ããžãšã³èªå°äœäž
ã®21â眮æåºããææã®å Žåã«ã¯ãå€åœ¢ãããå
ã¯ä»ã®åºã®å°å ¥ã«ãã眮ãæããŠãããã21â
OHã21âãšã¹ãã«åºãåã¯21âããçŽ ïŒ21â
ïŒåºãçš®ã ã®æ¹æ³ã§å°å ¥ããŠãããããŸãååš
ãã21âOHåºã21âåºã«å€æããŠããããäŸ
ãã°ãç±³åœç¹èš±ç¬¬3631077å·æ现æžãåç §ããã
ãã
æ²çŽ âãããã¯èçŽ âæŸåºå€ïŒreleasing
agentïŒãšã®åå¿åŸã«ãæ¬çºæã«ãã€ãŠãã®ãã
ã«ããŠåŸãããâ³4,9âãã¬ã°ããžãšã³èªå°äœäž
ã®21â眮æåºããææã®å Žåã«ã¯ãå€åœ¢ãããå
ã¯ä»ã®åºã®å°å ¥ã«ãã眮ãæããŠãããã21â
OHã21âãšã¹ãã«åºãåã¯21âããçŽ ïŒ21â
ïŒåºãçš®ã ã®æ¹æ³ã§å°å ¥ããŠãããããŸãååš
ãã21âOHåºã21âåºã«å€æããŠããããäŸ
ãã°ãç±³åœç¹èš±ç¬¬3631077å·æ现æžãåç §ããã
ãã
ææ©ã«ã«ãã³é
žåã¯ãã®å®èœèªå°äœïŒäŸãã°ã
é žã¯ãã©ã€ããããã¯é žç¡æ°Žç©ïŒãšã®åå¿ã«ãã€
ãŠã21âã«ã«ããã·åºããšã¹ãã«åããŠãããã
é žã¯ãã©ã€ããããã¯é žç¡æ°Žç©ïŒãšã®åå¿ã«ãã€
ãŠã21âã«ã«ããã·åºããšã¹ãã«åããŠãããã
21âäœã«ä»»æçã«ååšããã¢ã·ã«åºïŒïŒâ
18CïŒãé©åœãªã«ã«ãã³é žããèªå°ããŠãããã
ãã®ã«ã«ãã³é žã¯ãäŸãã°ãé ¢é žãããããªã³
é žãé ªé žãåèé žããšãã³ãé žãã«ããªã³é žããŠ
ã³ãã«ã³é žãã©ãŠãªã³é žããã«ããã³é žããŠã³ã
ã»ã³é žããªã¬ã€ã³é žãããªã¡ãã«é ¢é žãã·ã¯ãã
ã³ãã«âã«ã«ãã³é žãã·ã¯ãããã·ã«é ¢é žãããš
ãã«ããããªã³é žãå®æ¯éŠé žãã·ã¯ããªã¯ãã«é ¢
é žãããšããã·âé ¢é žãããã³ã¢ããã³ã¿ã³âã«
ã«ãã³é žã§ãããã¢ã·ã«åºã¯çœ®æããªãã§ããã
ãšã奜ãŸããã
18CïŒãé©åœãªã«ã«ãã³é žããèªå°ããŠãããã
ãã®ã«ã«ãã³é žã¯ãäŸãã°ãé ¢é žãããããªã³
é žãé ªé žãåèé žããšãã³ãé žãã«ããªã³é žããŠ
ã³ãã«ã³é žãã©ãŠãªã³é žããã«ããã³é žããŠã³ã
ã»ã³é žããªã¬ã€ã³é žãããªã¡ãã«é ¢é žãã·ã¯ãã
ã³ãã«âã«ã«ãã³é žãã·ã¯ãããã·ã«é ¢é žãããš
ãã«ããããªã³é žãå®æ¯éŠé žãã·ã¯ããªã¯ãã«é ¢
é žãããšããã·âé ¢é žãããã³ã¢ããã³ã¿ã³âã«
ã«ãã³é žã§ãããã¢ã·ã«åºã¯çœ®æããªãã§ããã
ãšã奜ãŸããã
ãã®æ°ããååç©ã¯ãäžè¬çã«ãé©åœãªè³Šåœ¢å€
ããã³ææã®å Žåã«ã¯ä»ã®æŽ»æ§å€ãšæ··åããåŸ
ã«ã溶液ããµã¹ãã³ãžãšã³ããšãã«ãžãšã³åã¯åº
圢è¬å€èª¿ååïŒåœæ¥è ã«ãšã€ãŠåšç¥ã®é å€ãäžž
å€ãã«ãã»ã«ãç³å€ãåè¬ã®ãããªãã®ïŒã®åœ¢æ
ã§ãéçµå£çãããã¯çµè žå ã«ãç¹ã«çµå£çã«ãŒ
ãã§æäžããŠãããã
ããã³ææã®å Žåã«ã¯ä»ã®æŽ»æ§å€ãšæ··åããåŸ
ã«ã溶液ããµã¹ãã³ãžãšã³ããšãã«ãžãšã³åã¯åº
圢è¬å€èª¿ååïŒåœæ¥è ã«ãšã€ãŠåšç¥ã®é å€ãäžž
å€ãã«ãã»ã«ãç³å€ãåè¬ã®ãããªãã®ïŒã®åœ¢æ
ã§ãéçµå£çãããã¯çµè žå ã«ãç¹ã«çµå£çã«ãŒ
ãã§æäžããŠãããã
æ¯æ¥æäžã®ããã®åäœæäžéåœãã®æŽ»æ§ç©è³ªã®
éïŒããªãã¡ãè¬åŠçã«æå¹ãªéïŒã¯ãçŽ0.05ä¹
è³çŽ2.5mgã奜ãŸããã¯çŽ0.1ä¹è³2.0mgã®ç¯å²å ã«
åãããåäœéã®æäžåœ¢æ ã«ã€ããŠã¯çµå£æäžã
奜ãŸããããŸããïŒæ¥åœãïŒåäœã®æäžãæã奜
ãŸãããç®çååç©ã®21âãšã¹ãã«ã¯ããŸããé
çµå£æäžã®ããã®é·æäœçšåŠåš 調ç¯å€ïŒïŒâ50mg
å蟌ïŒãšããŠåœ¹ç«ã€ã
éïŒããªãã¡ãè¬åŠçã«æå¹ãªéïŒã¯ãçŽ0.05ä¹
è³çŽ2.5mgã奜ãŸããã¯çŽ0.1ä¹è³2.0mgã®ç¯å²å ã«
åãããåäœéã®æäžåœ¢æ ã«ã€ããŠã¯çµå£æäžã
奜ãŸããããŸããïŒæ¥åœãïŒåäœã®æäžãæã奜
ãŸãããç®çååç©ã®21âãšã¹ãã«ã¯ããŸããé
çµå£æäžã®ããã®é·æäœçšåŠåš 調ç¯å€ïŒïŒâ50mg
å蟌ïŒãšããŠåœ¹ç«ã€ã
æ¬çºæã®ã¹ããã€ãååç©ã®LD50å€ã¯äžã«è¿°
ã¹ãéåžžã®æäžéãããã¯ããã«é«ãã
ã¹ãéåžžã®æäžéãããã¯ããã«é«ãã
æ¬çºæã®ãã¬ã°ãã³èªå°äœã®é»äœæå掻æ§
ïŒprogestational activityïŒãã¯ã©ãŠãã«ã°ã»ãŠã³
ã¯ãã³ïŒClaubergâJunkmannïŒè©Šéšã«ãã€ãŠæ¬¡
ã®æ§ã«å®æœããïŒK.JunkmannïŒArch.exper.
Path.u.Pharmakol.ïŒBd.223ïŒ1954ïŒ244ã253å
ç §ïŒãäœé800ã1200ïœã®æ£åžžãªè¥ãéã©ãããã
䜿ããããã«ãŸãæ°ŽïŒc.c.ã«æº¶è§£ããããšã¹ãã©ãž
ãªãŒã«0.5ÎŒïœïŒÎ³ïŒãé£ç¶ïŒæ¥éç®äžæ³šå°ã
ããïŒæ¥ç®ã«ãŽãæ²¹ïŒc.c.ã«æº¶è§£ïŒãããåŸãªãå Ž
åã«ã¯é飜å溶液ç¶ã§ïŒãããè©Šéšç©è³ªãåæ§ã«
ç®äžæ³šå°ãããåè¿°ã®ãšã¹ãã©ãžãªãŒã«æäžã¯ã
ã以é0.05ÎŒïœïŒÎ³ïŒã®éã§ã©ãããã殺ããŸã§
æ¯æ¥ç¶ãããè©Šéšç©è³ªã®æ³šå°åŸã倫ã ïŒæ¥ãïŒ
æ¥ã10æ¥ã14æ¥ã17æ¥åã³21æ¥ç®ã«æ°çŸœãã€ã®ã©
ãããã殺ãããã®åå®®ç²èã®ç¶æ ããã®åçµçµ
ç¹åçã«ãã€ãŠä»¥äžã®åŠãç¹æ°è©äŸ¡ããã
ïŒprogestational activityïŒãã¯ã©ãŠãã«ã°ã»ãŠã³
ã¯ãã³ïŒClaubergâJunkmannïŒè©Šéšã«ãã€ãŠæ¬¡
ã®æ§ã«å®æœããïŒK.JunkmannïŒArch.exper.
Path.u.Pharmakol.ïŒBd.223ïŒ1954ïŒ244ã253å
ç §ïŒãäœé800ã1200ïœã®æ£åžžãªè¥ãéã©ãããã
䜿ããããã«ãŸãæ°ŽïŒc.c.ã«æº¶è§£ããããšã¹ãã©ãž
ãªãŒã«0.5ÎŒïœïŒÎ³ïŒãé£ç¶ïŒæ¥éç®äžæ³šå°ã
ããïŒæ¥ç®ã«ãŽãæ²¹ïŒc.c.ã«æº¶è§£ïŒãããåŸãªãå Ž
åã«ã¯é飜å溶液ç¶ã§ïŒãããè©Šéšç©è³ªãåæ§ã«
ç®äžæ³šå°ãããåè¿°ã®ãšã¹ãã©ãžãªãŒã«æäžã¯ã
ã以é0.05ÎŒïœïŒÎ³ïŒã®éã§ã©ãããã殺ããŸã§
æ¯æ¥ç¶ãããè©Šéšç©è³ªã®æ³šå°åŸã倫ã ïŒæ¥ãïŒ
æ¥ã10æ¥ã14æ¥ã17æ¥åã³21æ¥ç®ã«æ°çŸœãã€ã®ã©
ãããã殺ãããã®åå®®ç²èã®ç¶æ ããã®åçµçµ
ç¹åçã«ãã€ãŠä»¥äžã®åŠãç¹æ°è©äŸ¡ããã
ïŒâŠçŽç²ãªãšã¹ããã²ã³ã«ããå¢æ®
ïŒâŠæ確ãªé»äœæãžã®å€å
ïŒâŠæ¿ããé»äœæãžã®å€å
ïŒâŠéåžžã«æ¿ããé»äœæãžã®å€å
ããããã®è©Šéšæ¥æ¯ã«ãïŒãïŒçŸœã®å¹³åå€ãè©
䟡ã®åºç€ã«ããããã®è©Šéšã«æŒããŠãç±³åœç¹èš±ç¬¬
3631077å·æ现æžã«é瀺ãããŠãã16αâãšãã«
â21âããããã·ââ³ïŒâ19âãã«âãã¬ã°ãã³
âïŒïŒ20âãžãªã³â21âããã«ããšãŒãã¯ã125
ÎŒïœã®æäžéã§ã¯æäžåŸïŒé±éãçµãŠã掻æ§ã瀺
ããïŒç¹æ°è©äŸ¡ïŒïŒã250ÎŒïœã®æäžéã«ãã€ãŠ14
æ¥ç®ã«å ããªæŽ»æ§ïŒç¹æ°è©äŸ¡1.3ïŒã瀺ããã
䟡ã®åºç€ã«ããããã®è©Šéšã«æŒããŠãç±³åœç¹èš±ç¬¬
3631077å·æ现æžã«é瀺ãããŠãã16αâãšãã«
â21âããããã·ââ³ïŒâ19âãã«âãã¬ã°ãã³
âïŒïŒ20âãžãªã³â21âããã«ããšãŒãã¯ã125
ÎŒïœã®æäžéã§ã¯æäžåŸïŒé±éãçµãŠã掻æ§ã瀺
ããïŒç¹æ°è©äŸ¡ïŒïŒã250ÎŒïœã®æäžéã«ãã€ãŠ14
æ¥ç®ã«å ããªæŽ»æ§ïŒç¹æ°è©äŸ¡1.3ïŒã瀺ããã
ããã«å¯ŸããŠãæ¬çºæã®ãã¬ã°ãã³èªå°äœã§ã
ã16αâãšãã«â21âããããã·ââ³4,9âïŒ19
âãã«ïŒâãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³â21
âããã«ããšãŒãã¯è©Šéšç©è³ªæäžåŸïŒæ¥ããã³ïŒ
æ¥ç®ã«æŒããŠïŒÎŒïœã®æäžéã§å åãªæŽ»æ§ïŒç¹æ°
è©äŸ¡3.4ïŒã瀺ããåèšç±³åœç¹èš±æ现æžäžã«é瀺
ã®ãã®ã«èŒã¹çŽ20å以äžã®åèšæŽ»æ§ã瀺ãããšã
å€æãããæŽã«ãåèšæ¬çºæååç©ã®21äœã«æ°Žé ž
åºãçµåããŠããååç©åã³ãã®äœçœ®ã«ïŒŠãçµå
ããŠããååç©ãè©Šéšç©è³ªæäžåŸïŒæ¥ããã³ïŒæ¥
ç®ã«æŒããŠããããïŒÎŒïœåã³16ÎŒïœã®æäžéã§
å åãªæŽ»æ§ïŒç¹æ°è©äŸ¡3.2ïŒã瀺ããåèšç±³åœç¹
èš±æ现æžäžã«é瀺ãããŠããååç©ãšæ¯èŒããŠã
ãããçŽ30ååã³çŽ10åçšåºŠã®åèšæŽ»æ§ãæããŠ
ããããšãå€æããã
ã16αâãšãã«â21âããããã·ââ³4,9âïŒ19
âãã«ïŒâãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³â21
âããã«ããšãŒãã¯è©Šéšç©è³ªæäžåŸïŒæ¥ããã³ïŒ
æ¥ç®ã«æŒããŠïŒÎŒïœã®æäžéã§å åãªæŽ»æ§ïŒç¹æ°
è©äŸ¡3.4ïŒã瀺ããåèšç±³åœç¹èš±æ现æžäžã«é瀺
ã®ãã®ã«èŒã¹çŽ20å以äžã®åèšæŽ»æ§ã瀺ãããšã
å€æãããæŽã«ãåèšæ¬çºæååç©ã®21äœã«æ°Žé ž
åºãçµåããŠããååç©åã³ãã®äœçœ®ã«ïŒŠãçµå
ããŠããååç©ãè©Šéšç©è³ªæäžåŸïŒæ¥ããã³ïŒæ¥
ç®ã«æŒããŠããããïŒÎŒïœåã³16ÎŒïœã®æäžéã§
å åãªæŽ»æ§ïŒç¹æ°è©äŸ¡3.2ïŒã瀺ããåèšç±³åœç¹
èš±æ现æžäžã«é瀺ãããŠããååç©ãšæ¯èŒããŠã
ãããçŽ30ååã³çŽ10åçšåºŠã®åèšæŽ»æ§ãæããŠ
ããããšãå€æããã
åºçºç©è³ªã®èª¿è£œäŸïŒ
(a) 58.3mlã®4Nã¯ãã é
žãã15.5ïœã®ïŒÎ²âãã
ããã·âïŒÎ±âããã¢âïŒÎ²ïŒ19âãªãã·ãâ
16αâãšãã«âãã¬ã°ãã³â20âãªã³ã180ml
ã®ã¯ãããã«ã äžã«æº¶è§£ãã溶液ã«æ¹æäžã«40
âã§30åéã«äºã€ãŠæ·»å ããããã®æ··åç©ã40
âã§ããã«ïŒ1/2æéæ¹æãããã®åŸã宀枩
ïŒçŽ25âïŒã«å·åŽãã77.5mlã®æ°Žãæ·»å ããã
ææ©å±€ãåé¢ããæ°Žå±€ãã¯ãããã«ã ã§ïŒåæœ
åºããã4.65ïœã®NaHCO3ïŒ1.55ïœã®Na2SO4ã
ãã³6.2mlã®ããªãžã³ãäžç·ã«ãªã€ãã¯ããã
ã«ã å±€ã«æ·»å ãããã®åŸããã³ãéã«ããå¡©
ãé€å»ããæ®åã¯ãããã«ã 溶液ãèžçºä¹Ÿåºã
ããæ®æž£ç©ãã¯ãããã°ã©ãã«ããïŒãã«ãš
ã³ïŒé ¢é žãšãã«ãïŒïŒïŒïŒããã®ããã«ããŠåŸ
ãããçæç©ããžâã€ãœãããã«ãšãŒãã«ïŒã
ããµã³ããçµæ¶åãããšãããèç¹123â126
âããαãïŒïŒ ïŒâ443ãïŒCH2Cl2äžïŒã®ïŒÎ²ïŒ19
âãªãã·ãâ16αâãšãã«ââ³ïŒâãã¬ã°ãã³
âïŒïŒ20âãžãªã³ã9.2ïœçããã
ããã·âïŒÎ±âããã¢âïŒÎ²ïŒ19âãªãã·ãâ
16αâãšãã«âãã¬ã°ãã³â20âãªã³ã180ml
ã®ã¯ãããã«ã äžã«æº¶è§£ãã溶液ã«æ¹æäžã«40
âã§30åéã«äºã€ãŠæ·»å ããããã®æ··åç©ã40
âã§ããã«ïŒ1/2æéæ¹æãããã®åŸã宀枩
ïŒçŽ25âïŒã«å·åŽãã77.5mlã®æ°Žãæ·»å ããã
ææ©å±€ãåé¢ããæ°Žå±€ãã¯ãããã«ã ã§ïŒåæœ
åºããã4.65ïœã®NaHCO3ïŒ1.55ïœã®Na2SO4ã
ãã³6.2mlã®ããªãžã³ãäžç·ã«ãªã€ãã¯ããã
ã«ã å±€ã«æ·»å ãããã®åŸããã³ãéã«ããå¡©
ãé€å»ããæ®åã¯ãããã«ã 溶液ãèžçºä¹Ÿåºã
ããæ®æž£ç©ãã¯ãããã°ã©ãã«ããïŒãã«ãš
ã³ïŒé ¢é žãšãã«ãïŒïŒïŒïŒããã®ããã«ããŠåŸ
ãããçæç©ããžâã€ãœãããã«ãšãŒãã«ïŒã
ããµã³ããçµæ¶åãããšãããèç¹123â126
âããαãïŒïŒ ïŒâ443ãïŒCH2Cl2äžïŒã®ïŒÎ²ïŒ19
âãªãã·ãâ16αâãšãã«ââ³ïŒâãã¬ã°ãã³
âïŒïŒ20âãžãªã³ã9.2ïœçããã
åæ§ãªæ¹æ³ã§ãïŒÎ²âããããã·âïŒÎ±âã
ãã¢âïŒÎ²ïŒ19âãªãã·ãâ16αâãšãã«â21
âãã«ãªãâãã¬ã°ãã³â20âãªã³ïŒã¢ã»ãã
ããªã«äžã§ããåéã®äœçšã«ããïŒÎ²âããã
ãã·âïŒÎ±ïŒ21âãžããã¢âïŒÎ²ïŒ19âãªãã·
ãâ16αâãšãã«âãã¬ã°ãã³â20âãªã³ãã
åŸãããïŒãšïŒÎ²ïŒ21âãžããããã·âïŒÎ±â
ããã¢âïŒÎ²ïŒ19âãªãã·ãâ16αâãšãã«â
ãã¬ã°ãã³â20âãªã³ãšããïŒÎ²ïŒ19âãªãã·
ãâ16αâãšãã«â21âãã«ãªãââ³ïŒâãã¬
ã°ãã³âïŒïŒ20âãžãªã³ãšïŒÎ²ïŒ19ãªãã·ãâ
16αâãšãã«â21âããããã·ââ³ïŒâãã¬ã°
ãã³âïŒïŒ20âãžãªã³ãšã«å€æããã
ãã¢âïŒÎ²ïŒ19âãªãã·ãâ16αâãšãã«â21
âãã«ãªãâãã¬ã°ãã³â20âãªã³ïŒã¢ã»ãã
ããªã«äžã§ããåéã®äœçšã«ããïŒÎ²âããã
ãã·âïŒÎ±ïŒ21âãžããã¢âïŒÎ²ïŒ19âãªãã·
ãâ16αâãšãã«âãã¬ã°ãã³â20âãªã³ãã
åŸãããïŒãšïŒÎ²ïŒ21âãžããããã·âïŒÎ±â
ããã¢âïŒÎ²ïŒ19âãªãã·ãâ16αâãšãã«â
ãã¬ã°ãã³â20âãªã³ãšããïŒÎ²ïŒ19âãªãã·
ãâ16αâãšãã«â21âãã«ãªãââ³ïŒâãã¬
ã°ãã³âïŒïŒ20âãžãªã³ãšïŒÎ²ïŒ19ãªãã·ãâ
16αâãšãã«â21âããããã·ââ³ïŒâãã¬ã°
ãã³âïŒïŒ20âãžãªã³ãšã«å€æããã
(b) 10ïœã®äºéç²æ«ãšïŒïœã®ïŒÎ²ïŒ19âãªãã·ã
â16αâãšãã«ââ³ïŒâãã¬ã°ãã³âïŒïŒ20â
ãžãªã³ãšãã40mlã®ã€ãœãããããŒã«ãš10mlã®
æ°Žãšã®æ··åç©äžã«æžæ¿ãããããã®æ··åç©ãçª
çŽ é°å²æ°äžã«éæµããã42mlã®é ¢é žã15åé滎
äžããªããæ·»å ãããã®åŸã該混åç©ãããã«
ïŒæééæµãããããã€ããTMïŒHyf10TMïŒ
ïŒãžãšãŒã³ã¹ãã³ãŽã€ã«ç€Ÿãã³ãã©ãå·ãã³ã
ãŒïŒçªè»åãéãç空éã«ããäºéãé€å»
ããéæ®æž£ãæããã€ãœãããããŒã«ïŒæ°Ž
ïŒïŒïŒïŒééïŒã§æŽæµããã30âã«å·åŽåŸã15
mlã®æ°Žäžã«4.2mlã®æ¿ç¡«é žãå ¥ãã液ãåå¿æ··
åç©ã«æ·»å ãã枩床ã40â以äžã«ä¿æãããçŽ
ïŒæéã®æ¹æåŸãåžæ°Žé žåãããªãŠã ã§PHãçŽ
ïŒã«èª¿æŽããèžçã«ãã€ãŠã€ãœãããããŒã«ã
é€å»ããæ²æŸ±ç©ãéããŠäžæ§ãšãªããŸã§æ°Žã§
æŽæµãããã¯ãããã°ã©ãã€ïŒãã«ãšã³ïŒã¢ã»
ãã³ãïŒïŒïŒïŒããã³ã¢ã»ãã³ããã®çµæ¶åã«
ãã€ãŠãïŒïœã®16αâãšãã«â19âããããã·
ââ³ïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³ïŒèç¹
177ã178âããαãïŒïŒ ïŒïŒ147ãïŒCH2Cl2äžïŒïŒã
çããã
â16αâãšãã«ââ³ïŒâãã¬ã°ãã³âïŒïŒ20â
ãžãªã³ãšãã40mlã®ã€ãœãããããŒã«ãš10mlã®
æ°Žãšã®æ··åç©äžã«æžæ¿ãããããã®æ··åç©ãçª
çŽ é°å²æ°äžã«éæµããã42mlã®é ¢é žã15åé滎
äžããªããæ·»å ãããã®åŸã該混åç©ãããã«
ïŒæééæµãããããã€ããTMïŒHyf10TMïŒ
ïŒãžãšãŒã³ã¹ãã³ãŽã€ã«ç€Ÿãã³ãã©ãå·ãã³ã
ãŒïŒçªè»åãéãç空éã«ããäºéãé€å»
ããéæ®æž£ãæããã€ãœãããããŒã«ïŒæ°Ž
ïŒïŒïŒïŒééïŒã§æŽæµããã30âã«å·åŽåŸã15
mlã®æ°Žäžã«4.2mlã®æ¿ç¡«é žãå ¥ãã液ãåå¿æ··
åç©ã«æ·»å ãã枩床ã40â以äžã«ä¿æãããçŽ
ïŒæéã®æ¹æåŸãåžæ°Žé žåãããªãŠã ã§PHãçŽ
ïŒã«èª¿æŽããèžçã«ãã€ãŠã€ãœãããããŒã«ã
é€å»ããæ²æŸ±ç©ãéããŠäžæ§ãšãªããŸã§æ°Žã§
æŽæµãããã¯ãããã°ã©ãã€ïŒãã«ãšã³ïŒã¢ã»
ãã³ãïŒïŒïŒïŒããã³ã¢ã»ãã³ããã®çµæ¶åã«
ãã€ãŠãïŒïœã®16αâãšãã«â19âããããã·
ââ³ïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³ïŒèç¹
177ã178âããαãïŒïŒ ïŒïŒ147ãïŒCH2Cl2äžïŒïŒã
çããã
åæ§ãªæ¹æ³ã§ãïŒÎ²ïŒ19âãªãã·ãâ16αâ
ãšãã«â21âãã«ãªãââ³ïŒâãã¬ã°ãã³â
ïŒïŒ20âãžãªã³ãšïŒÎ²ïŒ19âãªãã·ãâ16αâ
ãšãã«â21âããããã·ââ³ïŒâãã¬ã°ãã³â
ïŒïŒ20âãžãªã³â21âã¢ã»ããŒãïŒçžåœ21âã
ãããã·ååç©ã®ã¢ã»ãã«åã«ãã€ãŠåŸãã
ãïŒãšãã16αâãšãã«â19âããããã·â21
âãã«ãªãââ³ïŒâãã¬ã°ãã³âïŒïŒ20âãžãª
ã³ïŒèç¹194ã198âããαãïŒïŒ ïŒïŒ129â
ïŒCH2Cl2äžïŒïŒãš16αâãšãã«â19ïŒ21âãžã
ãããã·ââ³ïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³
â21âã¢ã»ããŒããšã«å€æããã
ãšãã«â21âãã«ãªãââ³ïŒâãã¬ã°ãã³â
ïŒïŒ20âãžãªã³ãšïŒÎ²ïŒ19âãªãã·ãâ16αâ
ãšãã«â21âããããã·ââ³ïŒâãã¬ã°ãã³â
ïŒïŒ20âãžãªã³â21âã¢ã»ããŒãïŒçžåœ21âã
ãããã·ååç©ã®ã¢ã»ãã«åã«ãã€ãŠåŸãã
ãïŒãšãã16αâãšãã«â19âããããã·â21
âãã«ãªãââ³ïŒâãã¬ã°ãã³âïŒïŒ20âãžãª
ã³ïŒèç¹194ã198âããαãïŒïŒ ïŒïŒ129â
ïŒCH2Cl2äžïŒïŒãš16αâãšãã«â19ïŒ21âãžã
ãããã·ââ³ïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³
â21âã¢ã»ããŒããšã«å€æããã
(c) ïŒmlã®8Nã¯ãã é
žããïŒïœã®16αâãšãã«
â19âããããã·ââ³ïŒâãã¬ã°ãã³âïŒïŒ20
âãžãªã³ã70mlã®ã¢ã»ãã³ã«å ¥ãã溶液ã«çªçŽ
é°å²æ°äžããã³15â以äžã®æž©åºŠã§æ·»å ããã宀
æž©ã§ïŒæéæ¹æããåŸã4.8mlã®ã¡ã¿ããŒã«ã
åå¿æ··åç©ã«æ»Žäžããªããæ·»å ããã
â19âããããã·ââ³ïŒâãã¬ã°ãã³âïŒïŒ20
âãžãªã³ã70mlã®ã¢ã»ãã³ã«å ¥ãã溶液ã«çªçŽ
é°å²æ°äžããã³15â以äžã®æž©åºŠã§æ·»å ããã宀
æž©ã§ïŒæéæ¹æããåŸã4.8mlã®ã¡ã¿ããŒã«ã
åå¿æ··åç©ã«æ»Žäžããªããæ·»å ããã
ããã«ïŒæéã®æ¹æåŸãã¯ãã å¡©ããã³ã
éããåå¿æ··åç©ã500mlã®æ°Žã«æ³šå ¥ãããã
ã®æ°Žæ§æ··åç©ãå¡©åã¡ãã¬ã³ã§æœåºããæœåºç©
ãå·åŽ2Næ°Žé žåãããªãŠã ã§æŽæµãããã¢ã«
ã«ãªå±€ããã«ãšã³ïŒãšãŒãã«ïŒïŒïŒã§æŽæµãã
ã€ãã§é ¢é žã§PH4.5ã®é žæ§ãšãããå¡©åã¡ãã¬
ã³ã§ã®æœåºãæœç©ç©ã®æ°Žã§ã®æŽæµãç¡«é žãããª
ãŠã äžã§ã®ä¹Ÿç¥ãæœåºç©ã®èžçºä¹Ÿåºãããã³æ®
枣ç©ã®ã¯ãããã°ã©ãã€ãŒïŒãã«ãšã³ïŒã¢ã»ã
ã³ïŒïŒïŒïŒã«ããã1.15ïœã®10βâã«ã«ããã·
â16αâãšãã«ââ³ïŒâãã¬ã°ãã³âïŒïŒ20â
ãžãªã³ïŒèç¹111â115âïŒå解ïŒããαãïŒïŒ ïŒïŒ
202ãïŒCH2Cl2äžïŒïŒãçããã
éããåå¿æ··åç©ã500mlã®æ°Žã«æ³šå ¥ãããã
ã®æ°Žæ§æ··åç©ãå¡©åã¡ãã¬ã³ã§æœåºããæœåºç©
ãå·åŽ2Næ°Žé žåãããªãŠã ã§æŽæµãããã¢ã«
ã«ãªå±€ããã«ãšã³ïŒãšãŒãã«ïŒïŒïŒã§æŽæµãã
ã€ãã§é ¢é žã§PH4.5ã®é žæ§ãšãããå¡©åã¡ãã¬
ã³ã§ã®æœåºãæœç©ç©ã®æ°Žã§ã®æŽæµãç¡«é žãããª
ãŠã äžã§ã®ä¹Ÿç¥ãæœåºç©ã®èžçºä¹Ÿåºãããã³æ®
枣ç©ã®ã¯ãããã°ã©ãã€ãŒïŒãã«ãšã³ïŒã¢ã»ã
ã³ïŒïŒïŒïŒã«ããã1.15ïœã®10βâã«ã«ããã·
â16αâãšãã«ââ³ïŒâãã¬ã°ãã³âïŒïŒ20â
ãžãªã³ïŒèç¹111â115âïŒå解ïŒããαãïŒïŒ ïŒïŒ
202ãïŒCH2Cl2äžïŒïŒãçããã
åæ§ãªæ¹æ³ã§ã16αâãšãã«â19âãããã
ã·â21âãã«ãªãââ³ïŒâãã¬ã°ãã³âïŒïŒ20
âãžãªã³ãš16αâãšãã«â19ïŒ21âãžãããã
ã·ââ³ïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³â21â
ã¢ã»ããŒããšãã10βâã«ã«ããã·â16αâãš
ãã«â21âãã«ãªãââ³ïŒâãã¬ã°ãã³âïŒïŒ
20âãžãªã³ãš10βâã«ã«ããã·â16αâãšãã«
â21âããããã·ââ³ïŒâãã¬ã°ãã³âïŒïŒ20
âãžãªã³ãšã«å€æããã
ã·â21âãã«ãªãââ³ïŒâãã¬ã°ãã³âïŒïŒ20
âãžãªã³ãš16αâãšãã«â19ïŒ21âãžãããã
ã·ââ³ïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³â21â
ã¢ã»ããŒããšãã10βâã«ã«ããã·â16αâãš
ãã«â21âãã«ãªãââ³ïŒâãã¬ã°ãã³âïŒïŒ
20âãžãªã³ãš10βâã«ã«ããã·â16αâãšãã«
â21âããããã·ââ³ïŒâãã¬ã°ãã³âïŒïŒ20
âãžãªã³ãšã«å€æããã
å®æœäŸ
0.68ïœã®æ²çŽ ãïŒmlã®ããªãžã³ã«å
¥ãããã®
ããïŒïœã®10βâã«ã«ããã·â16αâãšãã«ââ³
ïŒâãã¬ã°ãã³ïŒïŒ20âãžãªã³ã10mlã®ããªãžã³
ã«å ¥ãã溶液ã«æ»Žäžããªããæ¹æäžã«æ·»å ããã
ãã®æ··åç©ã40âã§çªçŽ äžã«çŽïŒ1/2æéæ¹æ
ãããã®åŸãæ°Žã«æ³šå ¥ããå¡©é žã§é žæ§åããå¡©å
ã¡ãã¬ã³ã§æœåºãããæœåºç©ãæ°Žã§æŽæµããç¡«é ž
ãããªãŠã äžã§ä¹Ÿç¥ãããã€ããTMãéããŠé
ããããªããïŒNoritïŒæŽ»æ§çãšå ±ã«ç ®æ²žããæ
åŸã«èžçºä¹Ÿåºãããæ®æž£ç©ããšãŒãã«ããçµæ¶å
ããã0.5ïœã®16αâãšãã«ââ³4,9âãã¬ã°ã
ãžãšã³âïŒïŒ20âãžãªã³ïŒèç¹98.0â98.5âã
ãαãïŒïŒ ïŒâ196ãïŒCH2Cl2äžïŒïŒãçããã
ããïŒïœã®10βâã«ã«ããã·â16αâãšãã«ââ³
ïŒâãã¬ã°ãã³ïŒïŒ20âãžãªã³ã10mlã®ããªãžã³
ã«å ¥ãã溶液ã«æ»Žäžããªããæ¹æäžã«æ·»å ããã
ãã®æ··åç©ã40âã§çªçŽ äžã«çŽïŒ1/2æéæ¹æ
ãããã®åŸãæ°Žã«æ³šå ¥ããå¡©é žã§é žæ§åããå¡©å
ã¡ãã¬ã³ã§æœåºãããæœåºç©ãæ°Žã§æŽæµããç¡«é ž
ãããªãŠã äžã§ä¹Ÿç¥ãããã€ããTMãéããŠé
ããããªããïŒNoritïŒæŽ»æ§çãšå ±ã«ç ®æ²žããæ
åŸã«èžçºä¹Ÿåºãããæ®æž£ç©ããšãŒãã«ããçµæ¶å
ããã0.5ïœã®16αâãšãã«ââ³4,9âãã¬ã°ã
ãžãšã³âïŒïŒ20âãžãªã³ïŒèç¹98.0â98.5âã
ãαãïŒïŒ ïŒâ196ãïŒCH2Cl2äžïŒïŒãçããã
å®æœäŸ
3.6ïœã®æ²çŽ ãš36mlã®ããªãžã³ãšã®æ··åç©ãã
5.50ïœã®10βâã«ã«ããã·â16αâãšãã«â21â
ãã«ãªãââ³ïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³ã
55mlã®ããªãžã³ã«å ¥ãã溶液ã«çªçŽ é°å²æ°äžã«æ¹
æäžã«æ·»å ããããã®æ··åç©ãçŽ110âã§çŽïŒå
éæ¹æäžã«å ç±ãããã®åŸã350mlã®æ°·æ°Žã«æ³šå ¥
ããã750mlã®2Nå¡©é žã§é žæ§åããåŸã«ãæ··åç©
ãå¡©åã¡ãã¬ã³ã§æœåºãããæœåºç©ãããªç¡«é žã
ããªãŠã ã®ïŒïŒ 溶液ã§æŽæµããã€ãã§äžæ§ãšãªã
ãŸã§æ°Žã§æŽæµãããã®åŸãç¡«é žãããªãŠã äžã§ä¹Ÿ
ç¥ããã也ç¥æœåºç©ãå¡©ãšå ±ã«ç ®æ²žãããã€ãã
TMãéããŠéããèžçºä¹Ÿåºãããæ®æž£ç©ã®ã¯ã
ããã°ã©ãã€ãŒïŒãããµã³ïŒé ¢é žãšãã«ïŒïŒïŒé
éïŒããã³ãšãã«ãšãŒãã«ããã®çµæ¶åã«ããã
2.2ïœã®16αâãšãã«â21âãã«ãªãââ³4,9â
ãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³ïŒèç¹104â105
âããαãïŒïŒ ïŒâ160°ïŒCH2Cl2äžïŒïŒãçããã
5.50ïœã®10βâã«ã«ããã·â16αâãšãã«â21â
ãã«ãªãââ³ïŒâãã¬ã°ãã³âïŒïŒ20âãžãªã³ã
55mlã®ããªãžã³ã«å ¥ãã溶液ã«çªçŽ é°å²æ°äžã«æ¹
æäžã«æ·»å ããããã®æ··åç©ãçŽ110âã§çŽïŒå
éæ¹æäžã«å ç±ãããã®åŸã350mlã®æ°·æ°Žã«æ³šå ¥
ããã750mlã®2Nå¡©é žã§é žæ§åããåŸã«ãæ··åç©
ãå¡©åã¡ãã¬ã³ã§æœåºãããæœåºç©ãããªç¡«é žã
ããªãŠã ã®ïŒïŒ 溶液ã§æŽæµããã€ãã§äžæ§ãšãªã
ãŸã§æ°Žã§æŽæµãããã®åŸãç¡«é žãããªãŠã äžã§ä¹Ÿ
ç¥ããã也ç¥æœåºç©ãå¡©ãšå ±ã«ç ®æ²žãããã€ãã
TMãéããŠéããèžçºä¹Ÿåºãããæ®æž£ç©ã®ã¯ã
ããã°ã©ãã€ãŒïŒãããµã³ïŒé ¢é žãšãã«ïŒïŒïŒé
éïŒããã³ãšãã«ãšãŒãã«ããã®çµæ¶åã«ããã
2.2ïœã®16αâãšãã«â21âãã«ãªãââ³4,9â
ãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³ïŒèç¹104â105
âããαãïŒïŒ ïŒâ160°ïŒCH2Cl2äžïŒïŒãçããã
å®æœäŸ
å®æœäŸã«ããããšåæ§ãªæ¡ä»¶ããã³çžåœãã
æ¹æ³ã§ã55mlã®ããªãžã³äžã®5.47ïœã®10βâã«ã«
ããã·â16αâãšãã«â21âããããã·ââ³ïŒâ
ãã¬ã°ãã³âïŒïŒ20âãžãªã³ãã36mlã®ããªãžã³
äžã®3.6ïœã®æ²çŽ ãšåå¿ããããåå¿æ··åç©ãåŠ
çããããšã«ãã€ãŠã1.5ïœã®16αâãšãã«â21
âããããã·ââ³4,9âãã¬ã°ããžãšã³âïŒïŒ20
âãžãªã³ïŒèç¹147â148âããαãïŒïŒ ïŒâ167.7ã
ïŒãžãªããµã³äžïŒïŒãçããã
æ¹æ³ã§ã55mlã®ããªãžã³äžã®5.47ïœã®10βâã«ã«
ããã·â16αâãšãã«â21âããããã·ââ³ïŒâ
ãã¬ã°ãã³âïŒïŒ20âãžãªã³ãã36mlã®ããªãžã³
äžã®3.6ïœã®æ²çŽ ãšåå¿ããããåå¿æ··åç©ãåŠ
çããããšã«ãã€ãŠã1.5ïœã®16αâãšãã«â21
âããããã·ââ³4,9âãã¬ã°ããžãšã³âïŒïŒ20
âãžãªã³ïŒèç¹147â148âããαãïŒïŒ ïŒâ167.7ã
ïŒãžãªããµã³äžïŒïŒãçããã
å®æœäŸ
1.9mlã®ããã«ãã€ã«ã¯ãã©ã€ããïŒmlã®ã¢ã»
ãã³ã«å ¥ãã溶液ãã1.6ïœã®16αâãšãã«â21
âããããã·ââ³4,9âãã¬ã°ããžãšã³âïŒïŒ20
âãžãªã³ãïŒmlã®ããªãžã³ããã³ïŒmlã®ã¢ã»ãã³
ã«å ¥ããæ¹æ溶液ã«ãâ10âã§çªçŽ é°å²æ°äžã«æ»Ž
äžããªããæ·»å ãããïŒâïŒâã§ã®16æéã®æ¹æ
åŸã3.5mlã®ããªãžã³ãšïŒmlã®æ°Žãæ·»å ããçŽïŒ
âã§ããã«ïŒæéå šäœãæ¹æãããã€ãã§ãåå¿
æ··åç©ãçŽ45âã§ïŒæéæ¹æãããã®åŸã200ml
ã®æ°·æ°Žã«æ³šå ¥ãããžãšãã«ãšãŒãã«ã§æœåºããã
æœåºç©ã15mlã®2Nç¡«é žã§é£ç¶çã«æŽæµãã10ml
ã®å·åŽ0.5Næ°Žé žåãããªãŠã 溶液ã§ïŒåæŽæµ
ããæåŸã«äžæ§ãšãªããŸã§æ°Žã§æŽæµããã
Na2SO4äžã§ä¹Ÿç¥ããèžçºä¹Ÿåºããããšã«ãã€
ãŠãïŒïŒïŒïœã®æ®æž£ç©ãçããããã®æ®æž£ç©ã
100ïœã®ã·ãªã«äžã§ãããµã³ïŒé ¢é žãšãã«ïŒïŒïŒ
ã§ã¯ãããã°ã©ãã«ããããšããã2.0ïœã®16α
âãšãã«â21âããããã·ââ³4,9âãã¬ã°ããž
ãšã³âïŒïŒ20âãžãªã³â21âããã«ããšãŒã
ïŒãαãïŒïŒ ïŒâ83.8ãïŒãžãªããµã³äžïŒã®æ²¹ãçã
ãã
ãã³ã«å ¥ãã溶液ãã1.6ïœã®16αâãšãã«â21
âããããã·ââ³4,9âãã¬ã°ããžãšã³âïŒïŒ20
âãžãªã³ãïŒmlã®ããªãžã³ããã³ïŒmlã®ã¢ã»ãã³
ã«å ¥ããæ¹æ溶液ã«ãâ10âã§çªçŽ é°å²æ°äžã«æ»Ž
äžããªããæ·»å ãããïŒâïŒâã§ã®16æéã®æ¹æ
åŸã3.5mlã®ããªãžã³ãšïŒmlã®æ°Žãæ·»å ããçŽïŒ
âã§ããã«ïŒæéå šäœãæ¹æãããã€ãã§ãåå¿
æ··åç©ãçŽ45âã§ïŒæéæ¹æãããã®åŸã200ml
ã®æ°·æ°Žã«æ³šå ¥ãããžãšãã«ãšãŒãã«ã§æœåºããã
æœåºç©ã15mlã®2Nç¡«é žã§é£ç¶çã«æŽæµãã10ml
ã®å·åŽ0.5Næ°Žé žåãããªãŠã 溶液ã§ïŒåæŽæµ
ããæåŸã«äžæ§ãšãªããŸã§æ°Žã§æŽæµããã
Na2SO4äžã§ä¹Ÿç¥ããèžçºä¹Ÿåºããããšã«ãã€
ãŠãïŒïŒïŒïœã®æ®æž£ç©ãçããããã®æ®æž£ç©ã
100ïœã®ã·ãªã«äžã§ãããµã³ïŒé ¢é žãšãã«ïŒïŒïŒ
ã§ã¯ãããã°ã©ãã«ããããšããã2.0ïœã®16α
âãšãã«â21âããããã·ââ³4,9âãã¬ã°ããž
ãšã³âïŒïŒ20âãžãªã³â21âããã«ããšãŒã
ïŒãαãïŒïŒ ïŒâ83.8ãïŒãžãªããµã³äžïŒã®æ²¹ãçã
ãã
21âããã¿ããšãŒãã21âãã«ããšãŒãã21â
ãžã¯ãâãªã¯ãã«ã¢ã»ããŒãããã³21âããªã¡ã
ã«ã¢ã»ããŒããçžåœããæ¹æ³ã§èª¿è£œããã
ãžã¯ãâãªã¯ãã«ã¢ã»ããŒãããã³21âããªã¡ã
ã«ã¢ã»ããŒããçžåœããæ¹æ³ã§èª¿è£œããã
以äžããããååç©ã®ç©æ§å€ã瀺ãã
αïŒïŒ 
ïŒãžãªããµã³äžïŒ
21âããã¿ããšãŒã â97.0
21âãã«ããšãŒã â88.5
21âã·ã¯ãâãªã¯ãã«ã¢ã»ããŒã â89.2
21âããªã¡ãã«ã¢ã»ããŒã â105.0ã
å®æœäŸ
(a) 0.15mlã®ã¡ã¿ã³âã¹ã«ããªãã«ã¯ãã©ã€ã
ãã0.42ïœã®16αâãšãã«â21âããããã·â
â³4,9âãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³ã
4.2mlã®ä¹Ÿç¥ããªãžã³ã«å ¥ããæ¹æ溶液ã«â20
âã§çªçŽ äžã«æ»Žäžããªããæ·»å ãããçŽâ20â
ã§ã®16æéã®æ¹æåŸããã®æ··åç©ã40mlã®æ°·æ°Ž
ã«æ³šå ¥ãããéåžžã®æ¹æ³ã«ãããCH2Cl2ã§ã®
æœåºã«ãã€ãŠã0.43ïœã®21âã¡ã·ã¬ãŒããçã
ãã
ãã0.42ïœã®16αâãšãã«â21âããããã·â
â³4,9âãã¬ã°ããžãšã³âïŒïŒ20âãžãªã³ã
4.2mlã®ä¹Ÿç¥ããªãžã³ã«å ¥ããæ¹æ溶液ã«â20
âã§çªçŽ äžã«æ»Žäžããªããæ·»å ãããçŽâ20â
ã§ã®16æéã®æ¹æåŸããã®æ··åç©ã40mlã®æ°·æ°Ž
ã«æ³šå ¥ãããéåžžã®æ¹æ³ã«ãããCH2Cl2ã§ã®
æœåºã«ãã€ãŠã0.43ïœã®21âã¡ã·ã¬ãŒããçã
ãã
(b) 0.24ïœã®ä¹Ÿç¥NaIãïŒmlã®ã¢ã»ãã³ã«å
¥ãã
溶液ãã0.42ïœã®21âã¡ã·ã¬ãŒãã10mlã®ã¢ã»
ãã³ã«å ¥ããæ¹æ溶液ã«å®€æž©ã§çªçŽ äžã«æ·»å ã
ããåå¿æ··åç©ã30åéç ®æ²žãããã®åŸã100
mlã®æ°·æ°Žã«æ³šå ¥ãããå¡©åã¡ãã¬ã³ã§ã®æœåºã
ãã³ãã®äžã®åŠçã«ããã0.37ïœã®21âã¢ã€ãª
ãã€ããçããã
溶液ãã0.42ïœã®21âã¡ã·ã¬ãŒãã10mlã®ã¢ã»
ãã³ã«å ¥ããæ¹æ溶液ã«å®€æž©ã§çªçŽ äžã«æ·»å ã
ããåå¿æ··åç©ã30åéç ®æ²žãããã®åŸã100
mlã®æ°·æ°Žã«æ³šå ¥ãããå¡©åã¡ãã¬ã³ã§ã®æœåºã
ãã³ãã®äžã®åŠçã«ããã0.37ïœã®21âã¢ã€ãª
ãã€ããçããã
(c) 0.34ïœã®21âã¢ã€ãªãã€ãã10mlã®ã¢ã»ãã
ããªã«ã«å ¥ãã溶液ããçªçŽ é°å²æ°äžããã³æ
æã§çŽ65âã«å ç±ããããã®æž©åºŠã§ã0.29ïœã®
AgFã1.2mlã®èžçæ°Žã«å ¥ãããµã¹ãã³ãžãšã³
ãã€ãã§æ·»å ãããåå¿æ··åç©ã65âã§24æé
æ¹æããã25âã«å·åŽåŸããã€ããTMãéã
éã«ãã€ãŠéå¡©ãé€å»ããããã€ã«ã¿äžã«æ®å
ããç©è ãCH2Cl2ã§æŽæµããå©ç©ãããŒã¿
ãªã€ãšããã¬ã€ã¿äžã§çŽïŒmlã®ãã«ã¯ã«å€ã
ãã40mlã®æ°·æ°Žã«æ³šå ¥åŸãåå¿æ··åç©ã
CH2Cl2ã§æœåºããæœåºç©ãéåžžã®æ¹æ³ã§åŠç
ãããšããã0.27ïœã®16αâãšãã«â21âãã«
ãªãââ³4,9âãã¬ã°ããžãšã³âïŒïŒ20âãžãª
ã³ïŒèç¹104â105âããαãïŒïŒ ïŒâ160ã
ïŒCH2Cl2äžïŒïŒãçããã
ããªã«ã«å ¥ãã溶液ããçªçŽ é°å²æ°äžããã³æ
æã§çŽ65âã«å ç±ããããã®æž©åºŠã§ã0.29ïœã®
AgFã1.2mlã®èžçæ°Žã«å ¥ãããµã¹ãã³ãžãšã³
ãã€ãã§æ·»å ãããåå¿æ··åç©ã65âã§24æé
æ¹æããã25âã«å·åŽåŸããã€ããTMãéã
éã«ãã€ãŠéå¡©ãé€å»ããããã€ã«ã¿äžã«æ®å
ããç©è ãCH2Cl2ã§æŽæµããå©ç©ãããŒã¿
ãªã€ãšããã¬ã€ã¿äžã§çŽïŒmlã®ãã«ã¯ã«å€ã
ãã40mlã®æ°·æ°Žã«æ³šå ¥åŸãåå¿æ··åç©ã
CH2Cl2ã§æœåºããæœåºç©ãéåžžã®æ¹æ³ã§åŠç
ãããšããã0.27ïœã®16αâãšãã«â21âãã«
ãªãââ³4,9âãã¬ã°ããžãšã³âïŒïŒ20âãžãª
ã³ïŒèç¹104â105âããαãïŒïŒ ïŒâ160ã
ïŒCH2Cl2äžïŒïŒãçããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ åŒ ïŒåŒäžãR1ã¯ïŒšïŒïŒŠïŒOHããã³OR2ããæã
矀ããéžæããããã®ã§ãã€ãŠãR2ã¯ïŒä¹è³18
åã®ççŽ ååãæããã¢ã·ã«ã§ããïŒãæããå
åç©ã ïŒ R1ãïŒOHåã¯OR2ã§ãã€ãŠãR2ãïŒä¹è³
18åã®ççŽ ååãæããã¢ã·ã«ã§ãããç¹èš±è«æ±
ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ R1ãã§ãããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒ
ã®ååç©ã ïŒ R1ãOHåã¯OR2ã§ãã€ãŠãR2ãããã«ãã€
ã«ã§ãããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ (a) åŒ ïŒåŒäžãR1ã¯ïŒšïŒïŒŠïŒOHããã³OR2ããæ
ã矀ããéžæããããã®ã§ãã€ãŠãR2ã¯ïŒä¹
è³18åã®ççŽ ååãæããã¢ã·ã«ã§ããïŒãæ
ããååç©ã®è¬åŠçæå¹éãšã (b) è¬åŠçã«æå¹ãªæ äœãšã ããæãããšãç¹åŸŽãšãããé»äœæåæåµæå¶æŽ»
æ§ãæããè¬å€çµæç©ã ïŒ R1ãïŒOHåã¯OR2ã§ãããR2ãïŒä¹è³18
åã®ççŽ ååãæããã¢ã·ã«ã§ãããç¹èš±è«æ±ã®
ç¯å²ç¬¬ïŒé èšèŒã®çµæç©ã ïŒ R1ãã§ãããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒ
ã®çµæç©ã ïŒ R1ãOHåã¯OR2ã§ãããR2ãããã«ãã€ã«
ã§ãããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®çµæç©ã ïŒ çžåœãã10âã«ã«ããã·ââ³ïŒâïŒâã±ãã³
ãé©åœãªè€çŽ ç°åŒç¬¬ïŒçŽã¢ãã³ã®ååšäžã«æ²çŽ ã
ããã¯èçŽ åã¯æ²çŽ æŸåºå€ãããã¯èçŽ æŸåºå€ãš
åå¿ãããããšãç¹åŸŽãšãããåŒ ïŒåŒäžãR1ã¯ïŒšïŒïŒŠïŒOHããã³OR2ããæã
矀ããéžæããããã®ã§ãã€ãŠãR2ã¯ïŒä¹è³18
åã®ççŽ ååãæããã¢ã·ã«ã§ããïŒãæããå
åç©ã®è£œé æ³ã
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL7710462A NL7710462A (nl) | 1977-09-26 | 1977-09-26 | Werkwijze voor het bereiden van nieuwe steroiden van de pregnaanreeks. |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5455558A JPS5455558A (en) | 1979-05-02 |
JPS6228157B2 true JPS6228157B2 (ja) | 1987-06-18 |
Family
ID=19829230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP11737778A Granted JPS5455558A (en) | 1977-09-26 | 1978-09-22 | Novel delta 4 * 99 pregnane derivative * production thereof and preemenstrual and 1 or ovulation conttrol agent containing same |
Country Status (14)
Country | Link |
---|---|
US (1) | US4223030A (ja) |
EP (1) | EP0001308B1 (ja) |
JP (1) | JPS5455558A (ja) |
AU (1) | AU523556B2 (ja) |
CA (1) | CA1110616A (ja) |
DE (1) | DE2861474D1 (ja) |
DK (1) | DK147375C (ja) |
ES (1) | ES473646A1 (ja) |
FI (1) | FI65263C (ja) |
HU (1) | HU181845B (ja) |
IE (1) | IE47744B1 (ja) |
IT (1) | IT1106081B (ja) |
NL (1) | NL7710462A (ja) |
ZA (1) | ZA785125B (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993007749A1 (en) * | 1991-10-23 | 1993-04-29 | Akzo Nobel N.V. | Pest control compositions |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL125068C (ja) * | 1964-06-01 | |||
NL6801449A (ja) * | 1968-02-01 | 1969-08-05 | ||
FR2143583A1 (en) * | 1971-06-30 | 1973-02-09 | Roussel Uclaf | 17-substituted pregna-4,9(10)-dienes - with antiandrogenic antigonadotrophic and antioestrogenic acivity |
-
1977
- 1977-09-26 NL NL7710462A patent/NL7710462A/xx not_active Application Discontinuation
-
1978
- 1978-09-08 ZA ZA00785125A patent/ZA785125B/xx unknown
- 1978-09-13 DE DE7878200187T patent/DE2861474D1/de not_active Expired
- 1978-09-13 EP EP78200187A patent/EP0001308B1/en not_active Expired
- 1978-09-15 DK DK409778A patent/DK147375C/da active
- 1978-09-15 AU AU39901/78A patent/AU523556B2/en not_active Expired
- 1978-09-15 US US05/942,594 patent/US4223030A/en not_active Expired - Lifetime
- 1978-09-19 IE IE1820/78A patent/IE47744B1/en unknown
- 1978-09-22 FI FI782895A patent/FI65263C/fi not_active IP Right Cessation
- 1978-09-22 JP JP11737778A patent/JPS5455558A/ja active Granted
- 1978-09-22 IT IT51213/78A patent/IT1106081B/it active
- 1978-09-25 HU HU78AO468A patent/HU181845B/hu unknown
- 1978-09-25 CA CA312,017A patent/CA1110616A/en not_active Expired
- 1978-09-25 ES ES473646A patent/ES473646A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
DK147375C (da) | 1985-01-28 |
DK409778A (da) | 1979-03-27 |
ES473646A1 (es) | 1979-10-16 |
US4223030A (en) | 1980-09-16 |
HU181845B (en) | 1983-11-28 |
DK147375B (da) | 1984-07-09 |
FI65263C (fi) | 1984-04-10 |
AU523556B2 (en) | 1982-08-05 |
IE781820L (en) | 1979-03-26 |
FI782895A (fi) | 1979-03-27 |
IT1106081B (it) | 1985-11-11 |
ZA785125B (en) | 1979-08-29 |
JPS5455558A (en) | 1979-05-02 |
AU3990178A (en) | 1980-03-20 |
CA1110616A (en) | 1981-10-13 |
EP0001308A1 (en) | 1979-04-04 |
EP0001308B1 (en) | 1981-12-30 |
FI65263B (fi) | 1983-12-30 |
IE47744B1 (en) | 1984-06-13 |
NL7710462A (nl) | 1979-03-28 |
DE2861474D1 (en) | 1982-02-18 |
IT7851213A0 (it) | 1978-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS6119640B2 (ja) | ||
US5972922A (en) | Steroids which inhibit angiogenesis | |
JP2783560B2 (ja) | æ°èŠãªã¢ã³ããã¹ã¿ã³ïŒïŒâã«ã«ãã³é žãšã¹ãã«ããã®è£œæ³åã³ãããå«ãè¬å€ | |
GB1599863A (en) | Pharmaceutical compositions for use in the inhibition of the biosynthesis of mevalonic acid | |
US4588530A (en) | Anti-inflammatory prednisolone steroids | |
JP2677626B2 (ja) | ïŒïŒâ眮æã¢ã³ããã¹ã¿âïŒïŒïŒâãžãšã³âïŒâãªã³èªå°äœ | |
JPS6228157B2 (ja) | ||
US3291690A (en) | 25-aza-cholestatrienes, process for production and method of treatment | |
JPH075629B2 (ja) | æ°èŠã¹ããã€ãååç©ããã³ãããå«ãå»è¬çµæç© | |
US3282785A (en) | 3-keto-4, 9-dienic-11beta-hydroxy-19-nor steroids useful in the treatment of hypercholesterolemia | |
US3757009A (en) | Re spiro-(steroid-17,2'-furan-3'-ones) and a process for their manufactu | |
US2705232A (en) | Ternorcholanylthiazoles | |
US3499013A (en) | 3-oxygenated 21beta-hydrocarbonsulfonyl-pregna-17(20),20-dienes,dehydro and 19-nor derivatives thereof and intermediates thereto | |
EP0005758B1 (de) | Verfahren zum Aufbau der Hydroxyacetyl-Seitenkette von Steroiden des Pregnan-Typs, neue 21-Hydroxy-20-oxo-17alpha-pregnan-Verbindungen und pharmazeutische PrÀparate enthaltend dieselben | |
CA1146533A (en) | 11-methylene steroids, process for their manufacture and pharmaceutical preparations containing them | |
US4390530A (en) | 3-Deoxy-Î15 -steroids | |
US3377342A (en) | 2', 2'-bistrifluoromethyloxetano(3', 4'; 16alpha, 17alpha)derivatives of 4-pregneno [3, 2-c]pyrazoles and 4, 6-pregnadieno [3, 2-c]pyrazoles | |
US3585191A (en) | Androstane derivatives | |
JPS6321680B2 (ja) | ||
JPS6337796B2 (ja) | ||
US3661940A (en) | Derivatives of 21-methyl-19-norpregnanes | |
IE46562B1 (en) | 17a-acetylene derivatives of androst-4-ene,processes for preparing them and pharmaceutical compositions containing them | |
US3462423A (en) | Cyano-derivatives of steroids | |
US5866559A (en) | 17α-cyanomethylestra-4,9-dien derivatives and pharmaceutical compositions containing same | |
JPS6230200B2 (ja) |